Skip to content

Can remimazolam administration prevent hypotension during induction?

Can remimazolam administration prevent hypotension during induction? - Can remimazolam administration prevent hypotension during induction?

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000059892
Enrollment
100
Registered
2025-11-26
Start date
2025-11-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing general anesthesia in the operation room

Interventions

Remimazolam is used as the induction agent during anesthesia, and hemodynamic parameters are monitored. Propofol is used as the drug for induction of anesthesia, and hemodynamic parameters are monitor

Sponsors

Tokyo Women's Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients aged 18 years or older who, after receiving adequate explanation regarding participation in this study, provided written consent based on full understanding and of their own free will 2.Patients with mild to moderate heart disease 3.Patients at risk of massive bleeding The above patient groups meet the criteria for HPI (Hypotension Prediction Index) insurance coverage. In these patients, induction of anesthesia may cause circulatory fluctuations, potentially leading to hypotension or bradycardia. This study aims to evaluate whether remimazolam use contributes to circulatory stabilization in this patient population.

Exclusion criteria

Exclusion criteria: 1.Severe heart disease (NYHA Class 3-4 heart failure, EF <30%, Rest angina or acute myocardial infarction within 3 months, uncontrollable severe arrhythmia, severe valvular disease such as aortic stenosis (AVA < 1.0 cm2, mean pressure gradient > 40 mmHg) or severe mitral regurgitation causing markedly impaired cardiac function, severe pulmonary hypertension (e.g., mean pulmonary artery pressure > 45 mmHg, cases with high risk of right heart failure) 2.Patients with allergies to the induction agent 3.Patients undergoing hemodialysis therapy 4.Patients with severe hepatic impairment (Child-Pugh class C or higher) 5.Patients with atrial fibrillation or atrial/ventricular premature contractions 6.Obese patients with BMI > 35 7.Patients in shock, e.g., mean blood pressure < 70 mmHg prior to anesthesia induction 8.Patients with failed initial oral endotracheal intubation 9.Cases where patient consent cannot be obtained despite family/proxy consent 10.Other patients deemed unsuitable for inclusion by the principal investigator

Design outcomes

Primary

MeasureTime frame
Comparison of Hypotension Incidence Between Groups from Anesthesia Induction to Pre-Surgical Intervention Hypotension is defined as a decrease in systolic blood pressure of 20% or more from baseline values, or a mean arterial pressure below 65 mmHg.

Secondary

MeasureTime frame
1.Comparison of the amount and frequency of vasopressor use, fluid volume administered, frequency and severity of hypotension, and duration (area under threshold curve and time-weighted average) during induction in both groups 2.Comparison of BP, HR, CVV, SVI, and CI in each group relative to baseline values (pre-induction)

Countries

Japan

Contacts

Public ContactTomoki Fukuda

Adachi Medical Center, Tokyo Women's Medical University Department of Anesthesiology

fukuda.tomoki@twmu.ac.jp03-3857-0111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026